Study of Lanreotide to Treat Polycystic Kidney Disease

Clinical trial NCT01616927 · UNKNOWN

Trial details

NCT number: NCT01616927
Sponsor: University Medical Center Groningen
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Start date: 2012-06-01
Primary completion: 2017-08-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.